Endocrine Disease and Anaesthesia 4 th year anaesthesia

  • Slides: 48
Download presentation
Endocrine Disease and Anaesthesia 4 th year anaesthesia tutorial MBCh. B

Endocrine Disease and Anaesthesia 4 th year anaesthesia tutorial MBCh. B

Diabetes Mellitus • Excessive production of sweet urine • Caused by absolute or relative

Diabetes Mellitus • Excessive production of sweet urine • Caused by absolute or relative insulin deficiency • Increasingly common disease Diabetes Insipidus - excessive production of tasteless urine

Diabetes Mellitus • Type I: – Onset often early – Absolute insulin deficiency –

Diabetes Mellitus • Type I: – Onset often early – Absolute insulin deficiency – Insulin dependent – Disorders of lipid metabolism common – Keto-acidosis a major feature – More severe end-organ disease • Type II: – Later onset – Relative insulin deficiency – Non-insulin dependent – Disorders of lipid metabolism rare – Hyperglycaemia may be severe

Acute Consequences of Hyperglycaemia • Dehydration – Fluid deficit 5 - 6 litres •

Acute Consequences of Hyperglycaemia • Dehydration – Fluid deficit 5 - 6 litres • Fatigue & weight loss • Na+, K+ and Mg 2+ deficiency

Chronic Complications of Diabetes Mellitus • Microvascular – Retinopathy – Diabetic nephropathy • Macrovascular

Chronic Complications of Diabetes Mellitus • Microvascular – Retinopathy – Diabetic nephropathy • Macrovascular – Atherosclerosis • Neuropathic – Autonomic and peripheral neuropathies

Treatment • Insulin – Short acting – Intermediate – Long • Sulphonylureas • Biguanides

Treatment • Insulin – Short acting – Intermediate – Long • Sulphonylureas • Biguanides • Other agents – Thiazolidinediones – Meglitinides – Alpha glucosidase inhibitors

Sulphonylureas • Enhance insulin secretion • Increase peripheral insulin sensitivity – May cause hypoglycaemia

Sulphonylureas • Enhance insulin secretion • Increase peripheral insulin sensitivity – May cause hypoglycaemia • Duration of action 6 - 24 hours

Biguanides Metformin • • Promote glucose utilisation Inhibit hepatic glucose production Less likely to

Biguanides Metformin • • Promote glucose utilisation Inhibit hepatic glucose production Less likely to cause hypoglycaemia Lactic acidosis: – Elderly – Renal / hepatic failure – Major surgery

The Surgical Challenge • Stress response evokes a hyperglycaemic response • If on insulin

The Surgical Challenge • Stress response evokes a hyperglycaemic response • If on insulin - Risk of hypoglycaemia due to interruption of food intake • Altered consciousness masking signs of hypoglycaemia • End-organ damage

Peri-operative Risks • • Coronary artery disease Diabetic cardiomyopathy Diabetic nephropathy Autonomic neuropathy Glycosylated

Peri-operative Risks • • Coronary artery disease Diabetic cardiomyopathy Diabetic nephropathy Autonomic neuropathy Glycosylated collagen Decreased wound healing Increased infection

Coronary Heart Disease • Risk of CHD increased 4 - 5 times • Silent

Coronary Heart Disease • Risk of CHD increased 4 - 5 times • Silent myocardial ischaemia

Diabetic Nephropathy • Commonest single cause of renal failure in USA • ACE inhibitors

Diabetic Nephropathy • Commonest single cause of renal failure in USA • ACE inhibitors may decrease longterm risk • No effective “renal protective drugs” – Dopamine does not help • Moderate fluid loading is the best protective strategy

Autonomic Neuropathy • Commoner in Type I than Type II – 40 % vs.

Autonomic Neuropathy • Commoner in Type I than Type II – 40 % vs. 15 % • Few patients are symptomatic • Impaired heart rate variability • Haemodynamic instability may occur – Risk increased in uraemic patients • Gastroparesis unresponsive to kinetic agents – May need RSI with cricoid pressure

Glycosylated Collagen • • Stiff joint syndrome “Praying hands” sign May affect cervical mobility

Glycosylated Collagen • • Stiff joint syndrome “Praying hands” sign May affect cervical mobility Possible difficult intubation – Minimal to moderate difficulty 5 % diabetics vs. 1 % in non-diabetics

The “prayer sign” may indicate the presence of glycosylated collagen Kim R P et

The “prayer sign” may indicate the presence of glycosylated collagen Kim R P et al. Clin Diabetes 2001; 19: 132 -135 © 2001 by American Diabetes Association

Wound Healing • Impaired in all diabetics – may be due to decreased neutrophil

Wound Healing • Impaired in all diabetics – may be due to decreased neutrophil function • Improved by long-term glycaemic control • More prone to wound infection

Pre-operative Evaluation 1. Identify type of diabetes 2. Determine quality of control Glycosylated Hb

Pre-operative Evaluation 1. Identify type of diabetes 2. Determine quality of control Glycosylated Hb 3. Evaluate end-organ dysfunction Neuropathies – autonomic + peripheral Renal function 4. Assess cardiovascular status BP, ischaemia (ECG)

Regional Anaesthetic • Reduced stress response • Better glycaemic control • Greater risk of

Regional Anaesthetic • Reduced stress response • Better glycaemic control • Greater risk of hypoglycaemia • Awake patient • Risk of hypotension with autonomic dysfunction • Legal risk of neuropathy • Spinal and epidural abscess • No evidence of improved outcome

General Anaesthesia • May be increased risks of haemodynamic instability • Possible aspiration risk

General Anaesthesia • May be increased risks of haemodynamic instability • Possible aspiration risk • Myocardial ischaemia • More difficult glycaemic control

Diabetics Minor Surgery • • Avoid hypoglycaemia Light snack before bed Omit insulin /

Diabetics Minor Surgery • • Avoid hypoglycaemia Light snack before bed Omit insulin / oral agents in the morning Check blood sugar prior to induction Early on the list Regional anaesthetic if possible Restart intake and regular insulin as soon as possible

Diabetics Major Surgery • Convert to sliding scale insulin for 24 hours if poorly

Diabetics Major Surgery • Convert to sliding scale insulin for 24 hours if poorly controlled • Omit morning dose and check blood sugar • Check blood sugar in theatre – On induction – Every hour • Insulin infusion or regular IV injections if indicated (watch K+) • Restart oral therapy as soon as possible

Intra-operative Insulin Therapy • Hourly sliding scale – Infusion with some dextrose – Infusion

Intra-operative Insulin Therapy • Hourly sliding scale – Infusion with some dextrose – Infusion with some potassium – Regular IV insulin bolus • Measure blood glucose and electrolytes

Insulin and Crystalloid • Ringer’s lactate Previously discouraged as there is – Poor lactate

Insulin and Crystalloid • Ringer’s lactate Previously discouraged as there is – Poor lactate handling in diabetics – Increased gluconeogenesis 0, 9 % saline thought to be preferable BUT Plasmalyte B or Ringer’s lactate is now preferred as it causes less acidosis!

Diabetic Ketoacidosis (DKA) May have a rapid onset - hours • Fluid resuscitation with

Diabetic Ketoacidosis (DKA) May have a rapid onset - hours • Fluid resuscitation with Ringer’s lactate / Pasmalyte B to establish urine flow • Intravenous insulin 0, 1 U kg-1 loading 0, 1 U kg-1 hr-1 until blood sugar < 12 mmol l-1 • Check blood sugar, K+ & ketones hourly • Replace K+ and Mg 2+ as indicated, once urine output established • Bicarbonate only if p. H < 7, 1

Hyperosmolar Non-ketotic Hyperglycaemia (HONK) Usually a slow onset - days • Very high plasma

Hyperosmolar Non-ketotic Hyperglycaemia (HONK) Usually a slow onset - days • Very high plasma osmolality • Fluid depleted • Replace fluids with isotonic fluids (not hypotonic fluid) • Gradual insulin administration • Lower blood sugar 3 - 5 mmol hr-1

Anaesthesia • • • Often require urgent surgery for sepsis Makes control difficult Do

Anaesthesia • • • Often require urgent surgery for sepsis Makes control difficult Do not anaesthetise until resuscitated Blood sugar < 20 mmol L-1 p. H > 7, 3 If possible ketosis controlled or at least improving

Postoperative • • Watch closely High mortality Insulin requirements can fluctuate Type II patients

Postoperative • • Watch closely High mortality Insulin requirements can fluctuate Type II patients may need DVT prophylaxis • Potassium can drop precipitously • Fluid requirements can vary widely

Glucose Control • Tight glucose control (4 – 8 mmol L-1) decreases mortality in:

Glucose Control • Tight glucose control (4 – 8 mmol L-1) decreases mortality in: – Cardiac anaesthesia – Brain injury – Trauma BUT Increases mortality from hypoglycaemia • Target 6 – 10 mmol L-1 • Treat < 4 or > 12 mmol L-1

Thyroid Disease • Euthyroid enlargement (goitre) • Thryotoxicosis • Hypothyroidism

Thyroid Disease • Euthyroid enlargement (goitre) • Thryotoxicosis • Hypothyroidism

Euthyroid Enlargement • Aetiology: – Iodine deficiency (goitre) – Malignancy • Pre-operative Assessment: –

Euthyroid Enlargement • Aetiology: – Iodine deficiency (goitre) – Malignancy • Pre-operative Assessment: – Airway – Retrosternal extension – Laryngeal nerve involvement • esp. with malignant lesions – Risk of hypothyroidism Clinical assessment adequate

Euthyroid Goitre • Anaesthesia: – Intubation – Flexible tube – Anaesthesia usually with controlled

Euthyroid Goitre • Anaesthesia: – Intubation – Flexible tube – Anaesthesia usually with controlled ventilation • Coughing • LMA may be adequate – Vocal cord assessment on extubation – Tracheomalacia

Postoperative • Extubate under direct vision (? LMA) • Recurrent laryngeal nerve damage 1

Postoperative • Extubate under direct vision (? LMA) • Recurrent laryngeal nerve damage 1 - 2 % but airway obstruction rare • Postoperative haematoma: – Secure the airway FIRST!! • Hypocalcaemia: – Transient in up to 20 % – Permanent 0 - 8 %

Thyrotoxicosis • Common condition affecting 2 % of women and 0, 2 % of

Thyrotoxicosis • Common condition affecting 2 % of women and 0, 2 % of men • Modern drugs make anaesthesia in thyrotoxicosis a rare event • Crisis usually follows another event e. g. pregnancy or malignancy • Do not anaesthetise until euthyroid

Thyroid Storm • May be precipitated by: – Anaesthesia – Surgery – Pregnancy –

Thyroid Storm • May be precipitated by: – Anaesthesia – Surgery – Pregnancy – Systemic illness (esp. infection) – Radio-active iodine therapy • Usually occurs late (hours) after the precipitating event

Management • Oxygen • Cooling • Intravenous fluids – Ringer’s or plamalyte B –

Management • Oxygen • Cooling • Intravenous fluids – Ringer’s or plamalyte B – 0, 9 % saline may worsen acidosis – Add dextrose

 -blockade • Usually treatment of choice – Control heart rate – Inhibit conversion

-blockade • Usually treatment of choice – Control heart rate – Inhibit conversion of T 4 to T 3 – High doses may be needed • Non-cardioselective agents preferred – Esmolol initially to establish dose range – Propranolol • Use with caution if cardiac failure or bronchospasm are present

Hypothyroidism • Aetiology: – Thyroiditis, radiation or surgery – Antithyroid drugs – Malignancy –

Hypothyroidism • Aetiology: – Thyroiditis, radiation or surgery – Antithyroid drugs – Malignancy – Pituitary failure • Symptoms: – Mental changes: ‘slowing’ – Hypertension, bradycardia, CCF – Anaemia, muscle dysfunction

Hypothyroidism • Diagnosis: – TSH always elevated except in pituitary failure – T 3

Hypothyroidism • Diagnosis: – TSH always elevated except in pituitary failure – T 3 and T 4 confirmatory • Preparation: – If severe, establish euthyroid state with SLOW administration of thyroxine • May precipitate myocardial ischaemia – Monitor TSH

Anaesthesia in Hypothyroidism • Sensitivity to drugs: – Anaesthetic agents – Opiates • Careful

Anaesthesia in Hypothyroidism • Sensitivity to drugs: – Anaesthetic agents – Opiates • Careful fluid balance • Ensure adequate reversal of neuromuscular blockade • Control hypoglycaemia and hypothermia

Phaeochromocytoma, Addison’s Disease Conn’s Syndrome • Very high risk • Specialist care • “Do

Phaeochromocytoma, Addison’s Disease Conn’s Syndrome • Very high risk • Specialist care • “Do not touch”

Endocrine Disease in Anaesthesia • Diabetes is a very common problem • Goitre is

Endocrine Disease in Anaesthesia • Diabetes is a very common problem • Goitre is common, but not a major problem • Other endocrine diseases are rare and require specialised care

Obesity

Obesity

Obesity • Not an endocrine disease per se, but a result of many contributing

Obesity • Not an endocrine disease per se, but a result of many contributing factors – Diet, exercise, genetics • In a small minority there may be an endocrine aetiology, e. g. Cushing’s • Conversely, obesity may cause type II diabetes and Syndrome X in susceptible individuals

Obesity Body mass index (BMI) Weight (kg) BMI = Height (m)2 • Obesity is

Obesity Body mass index (BMI) Weight (kg) BMI = Height (m)2 • Obesity is defined as a BMI > 30 kg m-² • Morbidly obese is a BMI > 35 kg m-²

Obesity • Patients are at increased risk of: – Hypertension – Ischaemic heart disease

Obesity • Patients are at increased risk of: – Hypertension – Ischaemic heart disease – Type II diabetes – Peripheral vascular disease – Hiatus hernia and – Gastro-oesophageal reflux